Cystic fibrosis macrophage function and clinical outcomes after elexacaftor/tezacaftor/ivacaftor is a research paper published in European Respiratory Journal (2022). On theSindex it has a DataRank of 0. It has been cited 54 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Cystic Fibrosis Foundation
Grant: KOPP16I0, PARTID18P0, MCCOY19RO
National Institutes of Health
Grant: R01HL158747, R01HL148171, R01AI24121, R01HL127651
NHLBI NIH HHS
Grant: R01 HL158747
NCATS NIH HHS
Grant: UL1 TR002733
NIAID NIH HHS
Grant: R01 AI124121
NIAID NIH HHS
Grant: R01 AI159452
NHLBI NIH HHS
Grant: R01 HL127651
NHLBI NIH HHS
Grant: R01 HL148171
MeSH Terms